• Privacy Policy
  • Editorial Policy
  • Advertise with us
  • Contact us
Tuesday, June 24, 2025
Glasgow Report
  • Home
  • World
  • News
  • Politics
  • Business
  • Sports
  • Technology
  • Entertainment
  • Health
  • Lifestyle
  • Science
  • Travel
No Result
View All Result
Glasgow Report
No Result
View All Result

Scots researchers discover breakthrough in treatments against Parkinson’s

by Glasgow Report
in Science


SCOTS researchers have discovered a breakthrough in future treatments against Parkinson’s disease.

Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein.

Parkinson’s disease is a progressive neurodegenerative disorder affecting more than 10 million people worldwide.

No cure is available and current treatment is limited to symptomatic management.

Dr Xingui Liu and Dr Alexia Kalogeropulou, leaders of the Dundee research team.
The University of Dundee research team is led by Dr Xingui Liu (L) and Dr Alexia Kalogeropulou (R).

Researchers from the University’s Centre for Targeted Protein Degradation (CeTPD) and MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) have made significant strides towards developing new therapies.

This is done through the design of XL01126, a small molecule that degrades a protein known to play a key role in the development of Parkinson’s.

The protein, Leucine Rich Repeat Kinase 2 (LRRK2), is one of the most important and promising targets for developing treatments for Parkinson’s disease.

Until now though, scientists have only been able to inhibit its function rather than destroying it completely.

XL01126 eliminates LRRK2 from within the cell by utilising the cell’s natural waste disposal system.

The research also demonstrated that XL01126 can be taken orally and can be detected in the brain in mice.

These are two sought-after features of drugs targeting neurodegenerative diseases that can be very challenging to achieve.

The Dundee team, led by Dr Xingui Liu and Dr Alexia Kalogeropulou, believe XL01126 will be a very useful research tool compound and has the potential to lead to therapeutics for Parkinson’s disease.

Dr Kalogeropulou said: “The discovery of XL01126 provides an exciting alternative strategy to target LRRK2 in addition to conventional LRRK2 kinase inhibitors.

“It can be a tool compound to decipher LRRK2 biology.”

Dr Liu added: “We are thrilled to see that XL01126 not only potently degrades LRRK2 in multiple cell lines, but also exhibits unexpected pharmacokinetic properties.

“Being orally bioavailable and blood-brain barrier permeable means that further development of PROTAC degraders as therapeutics for Parkinson’s disease is possible.”

XL01126 takes the field of targeted protein degradation (TPD) one step closer to developing drugs against neurodegenerative diseases.

The next steps in developing the treatment are currently underway with further pre-clinical studies to establish safety and effectiveness.

Targeted protein degradation co-opts the cell’s natural disposal systems to remove disease-causing proteins and is applicable to diverse therapeutic areas including oncology, inflammation, dermatology, immunology and respiratory diseases.

Dundee researchers and teams have previously revealed fundamental insights into the working of the degrader molecules that they have designed and that are used across the globe.



Source link

Previous Post

Interview with famous Environmental Artist and scientist Dr.Kasia Sterriker

Next Post

‘On stage I have a release’: the theatre making stars of care leavers

Related Posts

Resurgent tuna and rebounding elephants: the dogged conservation efforts bearing fruit

Resurgent tuna and rebounding elephants: the dogged conservation efforts bearing fruit

by Glasgow Report
June 19, 2025
0

When science meets with international co-operation, wildlife populations get a precious chance to recover It’s not easy being green these...

Genetic cancer risk testing has significant gaps

by Glasgow Report
June 12, 2025
0

AN EDINBURGH University study found that womb cancer patients lack screening for a genetic condition that raises their risk of...

Scottish Book Trust shines light on impact of libraries in the capital 

by Glasgow Report
June 5, 2025
0

THE Scottish Book Trust has released a report on the impact of libraries in Scotland.  The trust looked into the...

Next Post
‘On stage I have a release’: the theatre making stars of care leavers

‘On stage I have a release’: the theatre making stars of care leavers

  • Trending
  • Comments
  • Latest

Hindenburg Report on Adani Places Mr. Modi in Dilemma

February 10, 2023
Pandora’s Cube: A Mysterious Sum and a Sum of Mysteries

Pandora’s Cube: A Mysterious Sum and a Sum of Mysteries

May 19, 2023
A Brief on Kant’s Knowledge and Duty Reflections for “Glasgow Report”

A Brief on Kant’s Knowledge and Duty: Reflections for “Glasgow Report”

July 19, 2023
Dashcam footage shows impatient motorist yelling at driver in car park

Dashcam footage shows impatient motorist yelling at driver in car park

0
Social media users horrified by video of midges swarming hillwalker

Social media users horrified by video of midges swarming hillwalker

0
Scot horrified after finding poo-covered toilet brush in holiday apartment

Scot horrified after finding poo-covered toilet brush in holiday apartment

0
Top Invoice Finance Providers in the UK for 2025

Top Invoice Finance Providers in the UK for 2025

June 24, 2025
The stay-at-home-dad with a full to-do list and a full heart

The stay-at-home-dad with a full to-do list and a full heart

June 19, 2025

Life lessons: Patrick Grant on what life so far has taught him

June 19, 2025
Glasgow Report

Copyright © 2021 Glasgow Report.

Navigate Site

  • About
  • Advertise/Contribute
  • Privacy & Policy
  • Contact

Follow Us

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Sports
  • Technology
  • Lifestyle
  • Health
  • Travel
  • Science
  • Real Estate
  • Press Release

Copyright © 2021 Glasgow Report.